RMCM
Reynders McVeigh Capital Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,780
| Closed | -$299K | – | 237 |
|
|
2021
Q4 | $299K | Buy |
+6,780
| New | +$299K | 0.02% | 197 |
|
|
2020
Q4 | – | Sell |
-6,999
| Closed | -$263K | – | 230 |
|
|
2020
Q3 | $263K | Sell |
6,999
-8,786
| -56% | -$330K | 0.02% | 192 |
|
|
2020
Q2 | $644K | Buy |
+15,785
| New | +$644K | 0.06% | 124 |
|
|
2018
Q1 | – | Sell |
-8,709
| Closed | -$309K | – | 204 |
|
|
2017
Q4 | $309K | Sell |
8,709
-3,750
| -30% | -$133K | 0.04% | 170 |
|
|
2017
Q3 | $506K | Sell |
12,459
-400
| -3% | -$16.2K | 0.07% | 136 |
|
|
2017
Q2 | $554K | Buy |
12,859
+50
| +0.4% | +$2.15K | 0.07% | 129 |
|
|
2017
Q1 | $540K | Sell |
12,809
-200
| -2% | -$8.43K | 0.07% | 137 |
|
|
2016
Q4 | $501K | Sell |
13,009
-1,738
| -12% | -$66.9K | 0.07% | 139 |
|
|
2016
Q3 | $636K | Sell |
14,747
-1,124
| -7% | -$48.5K | 0.09% | 123 |
|
|
2016
Q2 | $688K | Sell |
15,871
-3,187
| -17% | -$138K | 0.1% | 121 |
|
|
2016
Q1 | $773K | Sell |
19,058
-2,406
| -11% | -$97.6K | 0.11% | 111 |
|
|
2015
Q4 | $866K | Sell |
21,464
-4,865
| -18% | -$196K | 0.14% | 92 |
|
|
2015
Q3 | $1.01M | Sell |
26,329
-5,699
| -18% | -$219K | 0.18% | 86 |
|
|
2015
Q2 | $1.33M | Sell |
32,028
-10,277
| -24% | -$428K | 0.22% | 74 |
|
|
2015
Q1 | $1.95M | Sell |
42,305
-35,278
| -45% | -$1.63M | 0.34% | 47 |
|
|
2014
Q4 | $3.32M | Sell |
77,583
-218,535
| -74% | -$9.34M | 0.58% | 40 |
|
|
2014
Q3 | $13.6M | Buy |
296,118
+53,590
| +22% | +$2.46M | 2.59% | 12 |
|
|
2014
Q2 | $13M | Buy |
242,528
+15
| +0% | +$802 | 2.95% | 8 |
|
|
2014
Q1 | $13M | Buy |
242,513
+7,880
| +3% | +$421K | 3.07% | 8 |
|
|
2013
Q4 | $12.5M | Buy |
234,633
+10,285
| +5% | +$549K | 3.1% | 8 |
|
|
2013
Q3 | $11.3M | Buy |
224,348
+11,563
| +5% | +$580K | 3.12% | 8 |
|
|
2013
Q2 | $10.6M | Buy |
+212,785
| New | +$10.6M | 3.15% | 7 |
|